Elderly Patients With Chronic Myeloid Leukemia Benefit From a Dasatinib Dose as Low as 20 mg - Concepedia

Concepedia

Publication | Closed Access

Elderly Patients With Chronic Myeloid Leukemia Benefit From a Dasatinib Dose as Low as 20 mg

29

Citations

21

References

2017

Year

Hidekazu Itamura, Yasushi Kubota, Takero Shindo, Toshihiko Ando, Kensuke Kojima, Shinya Kimura

Clinical Lymphoma Myeloma & Leukemia

Hematological MalignancyElderly PatientsGeriatricsMedicineHematologyPharmacotherapyDasatinib DoseOncologyMyeloid Neoplasia

References

	Year	Citations

Page 1